SCHEMBL4765667

SCHEMBL4765667

O=c1c([N+](=O)[O-])c(/C=C/c2cnn(Cc3ccccc3C(F)(F)F)c2)n(Cc2ccccc2F)c(=O)n1Cc1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.40
ADORA2B P29275 2/20 0.40
ADORA1 P30542 2/20 0.40
GNRHR P30968 3/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PKM P14618 2/20 0.37
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
SCD5 Q86SK9 1/20 0.34
EPHX2 P34913 1/20 0.33
GAA P10253 1/20 0.33
TAS2R8 Q9NYW2 1/20 0.33
C5AR1 P21730 1/20 0.33
PKLR P30613 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDE1A P54750 1/20 0.31
PDE1B Q01064 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4764053 0.94 ALDH1A1 (0.41) ADORA2AADORA2BADORA1ALDH1A1MAPT
SCHEMBL4769234 0.91 NPBWR1 (0.41) ADORA2AADORA2BADORA1GNRHRALDH1A1
SCHEMBL4767283 0.89 ADORA2A (0.35) ADORA2AADORA2BADORA1GNRHRALDH1A1
SCHEMBL4767273 0.89 ADORA2A (0.35) ADORA2AADORA2BADORA1GNRHRALDH1A1
SCHEMBL4771562 0.88 ADORA2A (0.39) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4771574 0.88 ADORA2A (0.39) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4763418 0.88 ADORA2A (0.39) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4763420 0.88 ADORA2A (0.39) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4767719 0.88 ADORA2B (0.45) ADORA2AADORA2BADORA1GNRHRALDH1A1
SCHEMBL4767733 0.88 ADORA2B (0.45) ADORA2AADORA2BADORA1GNRHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed